SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syncom Formulations wins ‘Product Excellence 2022’ award

23 May 2022 Evaluate

Syncom Formulations (India) has won ‘Product Excellence 2022’ award under the category of Pharma (Medium) at 6th IPF Industrial Excellence Awards 2022 organized by 3i Expo and brought by Industrial Product Finder Magazine on May 21, 2022 at Nehru Centre, Mumbai.

Syncom Formulations (India) Ltd. is engaged in the business of pharmaceutical formulations.

Syncom Formulations Share Price

14.29 0.41 (2.95%)
12-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.25
Dr. Reddys Lab 1273.90
Cipla 1388.80
Zydus Lifesciences 1104.35
Lupin 2292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: